Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

PostScription: Experts Everywhere

Author(s):  Rahe Hank

Issue:  Mar/Apr 2005 - Health and Wellness
View All Articles in Issue

Page(s):  167

PostScription: Experts Everywhere Page 1

Download in electronic PDF format for $65

Abstract:  Recent articles by individuals associated with the Controlled Environmental Testing Association (CETA) offer recommendations for barrier isolators used in pharmacy compounding. These recommendations are based, however, on misinterpretations of US Food and Drug Administration (FDA) policy, confusing guidelines for manufacturing with guidelines for compounding. United States Pharmacopeia (USP) Chapter <797> is an enforceable standard for compounding sterile preparations, while FDA regulations govern drug manufacturing processes. Great care has been taken in the construction of USP Chapter <797> to separate the requirements of manufacturing from the pharmacist’s right to compound. Compounding under the definitions and requirements outlined in USP Chapter <797> provide a safe environment without adding the more stringent requirements of the manufacturing environment. Confusing the requirements, as in the CETA documents, not only creates confusion but also endangers the intended separation of manufacturing and compounding.

Related Keywords: Hank Rahe, BSIM, MSE, barrier isolators, cleanroom, United States Pharmacopeia, USP Chapter <797>, US Food and Drug Administration, FDA, airflow, sterile preparation


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
Mar/Apr 2020
Pg. 92

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
May/Jun 2020
Pg. 180

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W
, Trissel Lawrence A
Jul/Aug 2004
Pg. 251-263

PostScription: Experts Everywhere
Rahe Hank
Mar/Apr 2005
Pg. 167

Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
Jul/Aug 2007
Pg. 302-305

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2007
Pg. 404-410

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124

Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Rahe Hank
Mar/Apr 2004
Pg. 89-94